GPCRs profiling and identification of GPR110 as a potential new target in HER2+ breast cancer
Raksha R. Bhat(University of Houston), Meghana V. Trivedi(University of Houston), Puja Yadav(University of Houston), Carmine De Angelis(Baylor College of Medicine), C. Kent Osborne(Baylor College of Medicine), Rachel Schiff(Baylor College of Medicine), Vidyalakshmi Sethunath(Dana-Farber Cancer Institute), Debashish Sahay(University of Houston), Chad J. Creighton(Baylor College of Medicine), Xiaoyong Fu(King University), Sarmistha Nanda(Baylor College of Medicine), Vihang A. Narkar(Brown Foundation), Vikas Yadav(Chaudhary Charan Singh Haryana Agricultural University), Lanfang Qin(Pancreatic Cancer Action Network), Sahar Yazdanfard(University of Houston), Ahmed Al-Rawi(University of Houston), Dharmendra Bhargava(University of Pennsylvania)
Cited by 25
Related Papers
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
|Neoplasia|2017|6.5k
UALCAN: An update to the integrated cancer data analysis platform
|Neoplasia|2022|2.5k
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k